Solrx Notes
Solrx Notes
NAPRA
Competencies are set forth by NAPRA.
NAPRA – National Association of Pharmacy Regulatory Authority
• It is an umbrella organization of Canada’s provincial pharmacy regulatory bodies
(eg. OCP, etc.)
• NAPRA outlines schedules
• In addition to the Provincial and Territorial Pharmacy Regulatory, the Canadian
Armed forces are part of NAPRA
• Their mission is to make sure that the public interest is always upheld, which is
accomplished by
o Representing the interests of the members organizations
o Serving as national resource center
Ex: This is where you can find the standards of practice for
pharmacy technicians
o Promoting the harmonization of legislation and standards
Ex: each state has its own needs and wants, how do you make it all
the same? NAPRA. If you go to one province, you should receive
same care as another. Your Rx should apply to different provinces.
In Canada you can transfer prescriptions across provinces (for
most drugs)
People in Canada are vastly distributed, different wants and needs.
NAPRA helps to harmonize all that
o NAPRA developed a set of national competencies
Standards for entrance into profession
Provincial regulatory bodies such as the OCP
Provide a guidelines for practice for pharmacists
• Who regulates the practice of pharmacy in Canada? In
Ontario, it is the OCP. It is the provincial regulatory
colleges. Regulate means control – license is control.
• NAPRA does not regulate! It provides guidelines.
o There are 7 main competencies set out by NAPRA
Patient Care
Professional collaboration and team work
Ethical, legal and professional responsibilities
Drug, therapeutic and practice information
Communication and education
Drug distribution
Understanding management principles
Pharmacists
What does a Pharmacist actually do?
• The pharmacist’s practice is based on these competencies, and all the NAPRA
definition of a registered/license pharmacists is who:
o Practices in accordance with professional registration and licensure, and
professional standards within his/her jurisdiction
o Possess broad-based and pharmacy specific knowledge.
o Uses critical thinking, problem solving, and decision making skills
appropriate to the pharmacist’s role
o Mentors pharmacists, students, interns, and pharmacy technicians or
others
o Takes responsibility for his/her own continuing professional development,
and commits to life long learning
Learning portfolio – we have to show evidence/proof that we are
always studying. Every province has its own template to keep track
of the CEs and lessons that you’ve done
• The pharmacist is the one who runs, manages the pharmacy and is allowed to
carry out any act involved in the Drug Distribution process!
o Eg: counseling, dispensing, putting through prescriptions, drug info, MD
interactions, etc.
o This doesn’t mean only the pharmacist can do these things. Especially
important in the last couple of years, because there has been a new
profession introduced – Pharmacy Technicians R.Ph.T. (it is a protected
title).
Pharmacy Technicians
• Why do we have Regulated Pharmacy Technicians?
o Need a standardized approach in this profession (regulation)
o Pharmacists have a greater ability to deal with patients with regulated
technicians. They can deal with the technical aspects of the distribution
process while pharmacists counsels.
o Pharmacy assistant vs Pharmacy technician
Assistant is not a protected title
Implication of protected title? It is a legal offense to call someone
who is not a technician one.
o Are there differences between registered technicians between provinces in
context to regulation of pharmacy techs?
There are some small differences, just like there is differences
between pharmacy roles in provinces.
But this is a national exam, so you worry about national things
o There are national standards for techs created by NAPRA – Model
Standards of Practice for Technicians
o On exam, if it’s a question about scope of practice, are they talking about
assistant or tech? Since almost every province has some legislation in
place for registered pharmacy techs, and the PEBC is testing for
CURRENT understanding of the profession, if mentioned pharmacy
technician, assume it is to be registered.
• Before and after regulation, what are the things a tech can do now?
o Receive new or repeat prescriptions from prescribers (techs couldn’t do
this before, now they can take verbal rx)
o Transfer prescriptions or receive prescriptions from other pharmacies (If
you go out of town, and need to transfer your med. Pharmacist used to
always have to do this, now registered tech can)
o Copy prescriptions for authorized recipients (can copy rx for doctors, for
transfer, etc.)
o Check pharmaceutical products prepared by another regulated pharmacy
technician or on their own (they can check the bottle, rx, etc, and then the
pharmacists sign off on it. Must be signed off before dispensed)
o Refer all inquiries and/or issues that require therapeutic decision to the
pharmacists (pharmacist has say on anything that has to do therapeutics)
o http://napra.ca/Content_Files/Files/Model_Standards_of_Prac_for_Cdn_P
harmTechs_Nov11.pdf Models of Practice for Techs (Look at Page 9)
• Why do we have R.Ph.T.? There is a need for educators (for diabetic educators, or
other topics). With a pharmacy technician available, pharmacists have more time
to do this.
• INSERT CHART OF PRE AND POST REGULATION
o Accepts new Rx for processing? Pre - Yes Post – Yes
o Accept verbal rx? Pre - No Post – Yes
o Release final product after completing final check to pt? Pre - No Post –
Yes.
(Every Rx whether new or repeat, must always be checked for
therapeutics by pharmacists. Pharm wont be worried about right
pill or right directions. Ex: Rx for Rampiril. When is it
cardioprotective? After MI, because remodeling of heart. This is
going to be a chronic med – longterm. If patient comes in and says
he changed his own dose to every other day – the pharmacists will
recognize therapeutics of this, not tech.)
o Complete transfer? Pre - No Post – Yes
o Need professional liability insurance? Pre - No Post – Yes
o Etc.
• After completing the final check in the rx process, within the scope of practice of
the new regulations, what must the regulated pharmacy tech do BEFORE giving
out the rx?
o Consult with the pharmacist to confirm that the prescription is
therapeutically sound. (doesn’t have to be at the end, pharmacist can
accept the rx, and talk to patient, screens therapeutic soundness of rx, then
can get it filled. Just as long it is checked by pharmacist at one point)
• Are registered techs allowed to check ALL prescriptions, including narcotics?
Yes! They can check all rx technically.
• What is an important condition with the verbal rx which registered pharmacy tech
can accept from a prescriber? They can only accept non-narcotic/controlled rx.
• Transfer – through fax. Can transfer verbally. Where can we transfer to?
Anywhere in Canada, not out of country.
• Are there any differences in the capacity or what kind of rx a registered pharmacy
tech can transfer v a pharmacist? Can not transfer narcotics regardless of your
role! The capacity and kind of rx that a tech and pharm transfer is the same.
• What can a pharmacy tech do?
o Assisting the pharmacist in the prep of rx
Can receive written rx, or request for a rx refill from patient or rep
Ensuring completeness of info on rx
Preparation of rx labels
Retrieving, counting, pouring, weighing, measuring and mixing
meds
Reconstituting medications (this is with water!)
Selecting type of prescription container
Affixing prescription and auxiliary labels to prescription containers
• Tech does not have therapeutic knowledge to know which
auxiliary
Pricing rx
Filing rx
o Clerical activities
Preparing and reconciling third party billings (drug plans from
employer or wtv, may have a premium, etc.)
Preparing receipts, invoices, letters, and memos, and general filing
Billing appropriate department for medication
Receiving and sending electronic communications
o Communication activities
o Inventory management
Monitoring stock levels to ensure sufficient quantities for optimal
operation (may want to increase stock at different times,
anticipatory increase in need)
Preparing and placing orders from specified sources
Maintaining inventory records, including those for narcotics and
controlled drugs
Rotating stock and monitoring expiry dates
Identifying expired products for disposal, destruction or return to
manufacturer
Prepackaging of medications (including unit dose packaging)
o Controlled acts only a registered pharm tech can do
Ethics
• A pharmacist has to deal with many ethical issues in his/her day to day practice
• There is a very fine line between ethics, morals and laws
Example situation
• 16 yo girl presents asking for Plan B, she seems anxious and makes sure no one is
watching or listening. Upon Questioning her, it was not forced upon on her, there
was consent (not a rape or sexual assult).
• What is Plan B?
o An emergency contraception.
o Is it an abortificient? No (pregnancy – is fertilization and implantation.
Plan B stops implantation, stops pregnancy from even occurring)
• Mechanism of action of Plan B?
o Active ingredient – levongesterol (progestin)
o MOA: thickens cervical mucous, changes motility of fallopian tubes -
which will effect the movement of ova sperm, and does not allow uterine
lining appropriate for implantation
• What counseling would you have for plan B?
o Are you pregnant? When was your last period? Can be used within 5 days,
best within 72 hours. Two tablets, taken 12 hours apart (not taken together
because of nausea)
o Does not require Rx
Autonomy
• This is the main principle of ethics
• Patient’s right to choose what is done to them
o When is a child too young to make choice for themselves? Person that is
mentally handicapped? Etc. You have to gauge the capacity to consent.
• Informed Consent
o Have to gauge the capacity to consent
o Competent minor (18 yr old is technically the age, but if the young pt
seems competent, then you don’t have to talk to the parent)
o Parental involvement
o Three things: pt must understand issues, treatment, and consequences.
• Example:
o Pt does not what to take new cholesterol medication. Pharmacist tries to
coerce her by telling her she can get a heart attack if she does not take her
meds. What ethical principle are you breaking? Autonomy (what you
should do: discuss disease state, warn them that it can lead to heart attack
by explaining it, explain the risk vs benefit)
Beneficence
• Care for the patient
• Acting in the best interest of the patient
• The well-being of the patient is at the center of professional practice
• There is risk of paternalism (telling the patient what to do, avoid this. Even if you
think you are doing it for the best of the patient. Educate, explain and make sure
they are aware and then the decision is theirs)
• Example
o Pt comes into pharmacy asking for an advance (extra pills once his is
finished).
His BP meds, doesn’t have any refills, and seeing the doctor in 4
days. What would you do? Yes you can, you would be illegally
giving it patient. What are you trying to uphold? Beneficence –
trying to make sure the patient is okay. Make sure you document
what you did and tell the doctor.
Non-maleficence
• Do no harm to the patient
• Balancing risks and benefits (if you know side effects are not worth it and you
give it, you are acting maleficently)
• We don’t use patients as guinea pigs! (don’t dispense medications that have not
been tested/approved)
• Only use treatment if medically necessary (ex: in surgery, you are removing one
organ, ex one ovary, and see it could effect another so you remove the other one
too, if there is no reason to you are violating non-maleficence
• Example:
o Patient, 27 years old, comes into the pharmacy to ask you for an advance
for: Cipro 500 mg as she is having similar symptoms as her previous UTI
when she successfully used cipro. She is seeing the doctor tomorrow
evening. What would you do? Not dispense. What ethical principle are
you trying to uphold? Non-maleficence (Explain: I understand your
situation, explain it could be due to a different cause, could do harm by
taking wrong medication, must see doctor)
Why does non-maleficence come before beneficence in this case?
This is not life threatening situation – more harm would be done
than good. If we did give the antibiotic it would be only one day,
wont make much different in the infection. Here it is more
important to do no harm.
o Working in a community pharmacy, you get a rx for morphine for a
broken arm. Based on calculated dose, it is very high, almost excessive.
You call the prescriber, explaining your concern, but she says that’s fine,
fill it as is. Thinking of the patient first, so you fill it, doing no harm
• Important to know which principles come first, because all may apply to a given
case. Look at the specific case!!
Veracity
• Patients have the right to the truth
• Honesty is the basis for trust
• There can be conflict of interests where one may be hesitant in being honest
o Business interests
Dispensing wrong med to someone you have a good relationship
with, still have to tell them. Or business benefit – ordering brand
name drug for your own benefit, and dispensing higher price brand
name instead of generic to patient and not giving them cheaper
option, not being honest.
o Pharmaceutical industry
• Example:
o Pt tells you that he has heard that Lipitor can be bad for your liver, is this
true. He also mentions that if it is true he will not take the drug. Must tell
him truth
Confidentiality
• Important in many professions
• Patient information is protected
o This is fortified by law – can be penalized (sued) for violating this
• Only shared in “circle of care” (can include nurses, pharmacists, caregiver,
physicians, family directly taking care of patient, other health care professionals,
etc.)
• Legal and ethical right of the patient
• Example:
o Police officer comes to you during evening shift and tells you he wants to
know if a pt of yours has valid rx for oxycontin. Do not tell him. Unless he
has a warrant you can deny telling him
Justice
• Fairness, equitable, consistent treatment of patients
• Consistent use of rules/laws with everyone
• Fair allocation of resources to all (this is what Canada is all about!)
• Example:
o John is well known pt at your pharmacy, where he gets expensive meds
and OTC products. Boss listed him as VIP pt and so he is not to wait for
prescriptions and bumped up to first. NOT right.
Scenario
• You are the pharmacist in a Family Health Team (FHT), and you have prepared
heparin injectables for anti-coagulation. Your clinic has a strict policy on
parenteral (anything that passes the GI tract) anti-coagulants, in light of a
medication error which costs the life of a patient. You find expired syringes in the
drawer. You talk to the RN (registered nurse) responsible for administration
o FHT – consists of doctors, nurses, pharmacists, etc. work together to make
best choice for patient
o She says: “I don’t have time for this! I have so much on my plate, so many
patients to take care of. What do you want from me ?!” The next thing you
say will determine if this goes in the right or wrong direction. Don’t
command her to do something, see if you can lessen the load and explain
the situation.
Patient-Centered Care
• Pharmacists have become more patient focused
• Pharmaceutical care is about the patient
• In order to do this, pharmacist needs to establish a trusting relationship
o Open exchange of information
o Patient can participate in their care (patient is master of their care)
o Reach therapeutic goals (what we want to reach with our drug therapy, ex.
Reduction in BP, cholesterol, blood glucose, etc.)
Scenario
• You’re working at a community pharmacy and you have a withdrawn patient
come up to you, not saying much, answering in one word answers, with a new rx.
o How would you approach this? Ask open ended questions (Ex: why did
you see the doctor? Or Tell me what’s going on.) Ask if theyd like to talk
in private counseling area
Question
• Based on what the Provincial and Federal government’s roles are, why is there
tension between the levels of government?
o There is tension because of conflict between the two – misunderstanding
Canadian Health Care
• Defining characteristic of Canadian identity (fair, equitable, should be universal)
o Which ethical principle doe this follow? Justice
Patent
• Exclusive rights to manufacture an innovative product
• Patents have an expiry date in Canada
• Currently, drug patents have an active life of 20 years from the date of filing in
Canada
o This is the minimum patent cycle allowed under our international trade
obligations
o A lot of these drugs are coming from the US. We have NAFTA (bilateral
trade between Canada and US – streamlines trade), pharmaceutical trade is
one of them but demanded 20 years.
• A 20-year patent cycle does not necessarily mean 20 years of market exclusivity
o It may take as many as 8 to 12 years for a new drug product to reach the
market in Canada
Case
• You have a pt who is retired patent lawyer, and he says to you while picking up
his “BRAND” medications that there should be no limit to patents, and that
generic companies are “thieves”. What would your response be?
o Not everyone will be able to afford third medication if not – cost!
o Company had their chance to make their money
o If companies wanted to charge whatever the wanted our country would go
broke.
Controversy Point
• If there is loss, damage/expiry, or theft of a narcotic who dwe contact
o Office of Controlled Substances (Health Canada)
o Have a form, you fill out, gives them details on matter
o Within 10 days of discovery
• For expired drugs, do we go ahead and destroy them after contacting the Office?
o NO
o Why not? Have to have permission, send letter to Office, then when it is
acknowledged, and get a letter back from office
• Same for controlled drugs as narcotic drugs.
• For benzodiazepines, you have to send letter out, but don’t have to wait for the
letter, can go ahead and destroy them.
Marihuana Medical Access Regulations
• Marijuana is not a therapeutic product in Canada or anywhere else in the world
• There is a program, where Health Canada implemented the Marijuana Medical
Access Regulations
• Define the circumstances and the manner in which to access marijuana
• Who is eligible to possess marijuana?
o Palliative care, spinal injury, cancer, spinal cord disease, HIV/AIDS
infection, severe forms of arthritis, seizures from epilepsy
• Applicants must provide a declaration from a medical practitioner to support their
application
How do you get medical Marijuana
• Health Canada gets dried marijuana and seeds from Prairie Plant Systems Inc.
• Patients have to fill out an application form, specific to the type of access they
need
• Health Canada website has a toll number
Summary
• Narcotics
o Written rx – yes; faxed rx – yes
o Verbal rx – no
o Refills – no
o Part fills – yes
o Transfers – no
o Needs a SALES REPORT
• Narcotics prep (verbal)
o Written rx – yes; faxed rx – yes
o Verbal rx – yes
o Refills – no
o Part fills – yes
o Transfers – no
o Note: exempted codeine products (OTC – 8 ng of codeine per tablet or
20mg/30 ml of liquids, with 2 non-narcotic ingredients)
• Controlled drugs: Part I
o Written rx – yes; faxed rx – yes
o Verbal rx – yes
o Refills – yes for written rx, only with # of refills
o Part fills – yes
o Transfers – no
• Controlled drugs: Part II, III
o Written rx – yes; faxed rx – yes
o Verbal rx – yes
o Refills – tes
o Part fills – yes
o Transfers – no
• Benzodiazepines
o Written rx – yes; faxed rx – yes
o Verbal rx – yes
o Refills – yes (for 1 year only)
o Part fills – yes
o Transfers – yes (once)
Drug Distribution
Drug distribution
• System designed to facilitate the safe transfer of a drug or medical device from
the manfucarere to the patient
• The integrity of the drug or medical devise is maintained
• The safety to the patient is maintained
• Steps include:
o Manufacturing, storage, procurement, dispensing, administration and
returns
• In response to the order of a prescriber
Important:
• Provide the right drug, in the right dosage form, in the right strength, to the right
patient, at the right time
• FIVE RIGHTS must be achieved for a complete and accurate drug distribution to
be carried out
Long-term Care
• What is it? Senior citizen home, retirement home. Different levels of care that
someone needs.
• What kind of patients would this apply to? Elderly, those that need assistance in
daily living, mental incapacitated patients, etc.
• Why do we have this setting? People want to maintain their lives but need help,
this is medium ground
• Pharmacist’s role? Home visits, med-checks, contracts with one pharmacy for all
prescriptions. Long term care facilities do not have in patient pharmacies.
• Accommodations for residents
• Have supported care and treatment
• Professional services
o Physicians, nurses, etc
• Different levels (independent living, etc.)
Recognizing parts of the Prescription
• Prescription heading (has MD name, address, number, etc)
• Name of patient
• Date written
• RX – superscription
• Inscription (name of drug)
• Sig
• Mitte (subscription)
• Prescribers signature
• Refills
Phase I
• Human volunteers
o ADME
o System that may be effecte
o Doses tested
o Single Ascending Dose (SAD) or Multiple Ascending Dose (MAD)
• Bioavailability and bioequivalence
o Rate, equivalence
Phase II
• …
Phase III
• Large scales trials with doses from Phase II; any patients
• Why do we want to do this? We want a large sample because it removes bias,
more powerful to say drug works in many
• Large sample size
• Could be against historical controls
• Placebo, or comparator “Gold Standard” Clinical trial
o Randomized, double blind, comparative phase III study
o Compare your drug to the first line drug being used
Phase IV
• Post-marketing surveillence – after it has been approved for marketing
After approval recommendations / rejecting (NDC, NDNC, DIN). Then final processing
• Get your DIN at the end –
Governing Bodies
• Prior to market authorization
o Health Canada
….?
Advertising Agencies
• Agencies that provide advisory opinions on messages directed to consumers for rx
drugs an don educational materials discussing a medical condition or disease
• Advertising standards Canada
• Pharmaceutical advertising advisory board
• In Canada: they can show the drug and say speak to your doctor, cannot say more
• Advertising Standards Canada
• PAAB – Pharmaceutical Advertising Advisory Board
Pharmacoeconomics
Pharmacoeconomics
• What is the need?
o Limited resources and unlimited wants
• What does that mean? In hospital drugs are covered, ODB, etc. Unlimited wants,
we need to be resourceful with our sources.
• Examples:
o Is it worthwhile for a provincial Ministry of Heath to reimburse
pharmacists at a rate of $300 per patient for disease management program
in congestive HF?
Definition:
• Description and analysis of cost ad consequences (risks/benefits) of
pharmaceutical …
Pharmacoecnomic Methods
• Cost-minimization Analysis
o When alternatives are equal, which is least expensive
o Useful for different new drug dosages
• Cost-benefit analysis
o Costs and benefits in monetary terms
o Ratio of benefits and cost
• Cost effectiveness analysis
o Health consequences measured in natural units of health (eg. Life saved,
life year gained, case cured, disability day avoided)
• Cost-utility analysis
o Variation of CEA in which ALL health outcomes are valued using a
metric called a quality-adjusted life year (QALY)
o Each year of life is weighed by its quality of life using a “utility” weight
(scale of 0 (dead) to 1 (excellent health)] and these weighted life years are
summed over all years of life.
Important Concepts
• Cost consideration of drug and drug product selection
o Cost differential between therapeutic agents
o Cost differential between brand and generic
o Cost differential between dosage forms and routes of administration
Why is this important? If it’s IV or parenteral it will cost more –
have to pay for nurse to admin, pump, etc important to look at too
• Economic considerations in therapeutically equivalent treatment
Pharmacy Management Principles
Management Expectations for Pharmacists: General
• Apply knowledge, skills, principles of management with the intention of
improving patient care and inter-professional collaboration
Planning: Pharmacy
• The first step
• Involves vision, goals, and objectives
• Strategic planning
o Operations of pharmacy
Are we going to have a niche? Going to focus on compounding,
chemotherapy, etc.
o Organizations of pharmacy
Where to place your products, compounding area, etc.
• Marketing Pharmacy services
o Want to show your services so that people will come to you.
o Ex: wants to promote compliance packaging, so you make a package of
info for doctors to show the service you offer.
• Ex: David the pharmacists and owner of ABC Pharmacy, which ash been open for
2 years wants to cater to local nursing homes in area. There has been a steady
growth in number of senior patients in his area, as there are new developments for
retirement and nursing homes. David is a certified geriatric drug therapy
specialist, and already serves many seniors… New home is 20 km away. Rexall
pharmacy available
o S: serves seniors
o W: only been open for 2 years, 20 km away
o O: senior homes, steady growth
o T: Rexall (other pharmacy)
Organizing: pharmacy
• Who are the members of the pharmacy team?
o Pharmacy Manager, Pharmacist
o Pharmacy intern, technician, assistant
• When is it good to have a triangle structure (levels, manager on top)?
o In times of crisis, or high stress, if you need to disseminate info very
quickly, leader steps up and delegates roles.
• When is it good to have a flat structure (everyone is equal)?
o Good for times of steady work, equilibrium, not a lot of change
Case
Patient who has been filling his rx or over 10 years. He’s elderly, and has several
comorbidities and now, several chronic meds. There have been several phone
calls he’s made because he forgets which medication to take, what each mediation
is for, and how to take them.
o What to do? Blister pack!
Note: Take with lots of water – ciprofloxacin, levofloxacin, norfloxacin (mainly used for
UTI, concentrates in the urinary tract, renally cleared, to flush med our and relieve
infection we need lots of fluid). Fluoroquinolones are mostly excreted unchanged.
Moxifoxacin is hepatically cleared so you don’t need lots of water (moxi is used for chest
infections, not UTIs)
Name of Medication on a Rx
Brand Name: is the name for which the innovator company holds a patent
o Eg: Teva-hctz, Lipitor, etc.
Generic Name: non-patented name, usually includes drug chemical names
o Eg: hctz, atorovastatin, etc.
o This is the chemical name ONLY, everything else is considered brand
name
Trade Names
Both the brand names and generic names such as Avandia, Norvasc, Apo-Hydro,
etc. are TRADE NAMES
Note: there’s a difference in actual name and??
Bioavailability Studies
Each volunteer receives the original brand name drug and the new generic drug
on two separate occasions
The generic drug must show that it can deliver the same amount of medicinal
ingredient at the same rate as the original drug
Drug Interchangeability (DIDFA)
“Interchangeable product” =
o Drug or combo of drugs in a particular dosage form and strength identified
by a special product name or manufacturer
o Designated with one or ore other such as products (products which are
interchangeable)
Where do you find if a drug is interchangeable? Formulary
Wont ask us about DIDFA because it is provincial
“No Sub”
Stands for No Substitution
Principles of interchangeability no longer apply
We have to give the brand that the doctor requested! Cannot give generic
For a written rx: “no sub” or “no substitution” must be in doctor’s own
handwriting
If it is verbal rx: you can write it for doctor
Topical medications
Cream, gel, ointment, lotion
o What’s the difference? Water content (greatest is lotion, then cream then
ointment, ointment is mostly oil)
o When do you use lotion vs ointment? Hair, face
o What makes a gel use? Drying effect (key!), acne preps are often gel
o What is a paste? Has more powder/solids, stays in place
Usually applied on the skin
Main purposes
o Protect area from environment, helps skin recover
o Hydration
o Deliver medication ‘
Advantages of topical agents
o Avoidance of GI tract
o Avoid first pass effect
First pass: Metabolized through liver before being full distributed
to the body. (Any kind of reaction can occur here – reduction,
hydrolysis, etc. this modifies the drug and effects availability)
• Which drug is
Topical agents bypass the portal vein
o Control of absorption
Disadvantages of topical agent
o Potential for localized irritation
o Time needed for diffusion through skin
o Dosage limitations (cant put too much of the drug)
Lotions and creams have a saturation point
o Lack of standardized administration amongst patients
o Change in skin physiology caused by
Age (as we age water content decreases), disease (psiorisis, or
eczema, cuts or wounds could cause excessive absorption), diet,
genetics, etc.
Parenteral Administration
Parenteral = avoid the intestine (therefore injection)
Subcutaneous (SC) Route
o Beneath the skin (under cutaneous or fatty tissue; above muscles, BVs)
o Sites include upper arm, lower ab, anterior surface of thigh
o Used for intermittent injection (SC)
Intradermal
o Into the dermis (vascular layer of skin, under the epidermis, above SC)
o Site is anterior …
IM
o Injection into muscle
o Site include deltoid (upper arm), gluteal (butt), vastus lateralis (thigh)
o Depot medications
o Onset of action is slower than IV but more rapid than subcutaneous
(muscle is richly vascularized, have lots of blood vessels! so onset is
slower, but more rapid than SC)
o Less risk and easier than IV, but more painful because you need longer
needles.
IV use
o Maintain access to CV system
o Administer drugs
o Maintain fluid requirements (restore and replace)
o Administer nutrition (TPN)
o Advantages:
Rapid onset (right into blood), immediate access to CV system
For drugs too difficult or irritating to administer via IM or SC
• Not everything can be administered IM – may get
crystallization of the medication, causes irritation and pain
Can give drugs and fluids which you cant give any other way
o Disadvantages
Have rapid onset, therefore rapid onset of adverse reactions
Irreversible admin
Risk of infusion of air, microorganisms, pyrogens, particular
matter
Risk of sepsis (infection), phlebitis, extravasation/infiltration
(leaking outside vein)
Comparison
o Fastest to slowet onset …..
o Get this from nada
IV Admin Sites
Peripheral sites (vein in hand or forearm; scalp or foot vein in infants, which is
possible but a central IV site is preferred in neonates) ie. Heparin/saline lock
Central IV sites (inserted into chest, tunneled under skin)
Bolus IV Injection
Large dose, starting dose, STAT dose, etc.
IV push, IV bolus
One time dose
Can be used as loading dose
o If you have an infection and need IV antibiotics, means it is an aggressive
infection, so need aggressive treatment
Intermittent IV Admin
Medication given from time to time
Iv bolus at Y-site or heparin/saline lock
o Heparin/saline lock: Y-connector on IV. There is a heparin lock to make
sure when you are done infusing heparin (because you have to mix it with
saline), you lock it, so if you give a bolus later, you unlock. Prevents you
from keeping going back in the patient if heparin is needed.
Medication given by piggyback minibag (medications run side by side, why?
Cant mix the medications until they are in the patient)
Continuous infusion
Constant therapeutic drug levels
Typically for drugs with short half life
Slow onset of action without a loading dose
Epidural
Into the spine specifically into the epidural space in the central cavity between the
dura matter ad the vertebral column
Intrathecal
Into the brain, specifically into the subarachnoid space underneath the arachnoid
matter in the brain where there is CSF (cerebrospinal fluid)
o This is sterile space, not in contact with blood.
o BBB is extremely lipophilic (can be helpful when designing drugs. Drugs
have to be uncharged)
Used for pain control
Storage Conditions
Some drugs require special storage conditions
Important as a pharmacist to: …
Temperature
o Room Temp – 15-30 C; Fridge – 2-8 C; Freezing – -20 C
Ex: Fridge (Clindoxyl gel, Xalatan, Nuvaring, fludricortisone)
Light
o Some medications are photosensitive
o Have to store them in light protective containers or vials
Which should you keep in original containers? Antiretroviral, Aggrenox
Precursor Control Regulations
Precursor Control Regulations under the Controlled Drugs and Substance Act
(Regulation)
Provides a regulatory framework
That enables Canada to address domestic concerns …
Helps keep certain drugs out of reach
Two classes:
o Class A precursor are essential components of illicit substances, such as
methamphetamine, MDMA, cocaine, etc.
o Class B precursors are mostly solvents, diluents, acetone, etc.
Impact on pharmacies
o Pharmacies are closed as general retailers, whose commerce is not
Pseudoephedrine-containing products that will be limited to 3g per package size
Pharmacies will be required to have a license if they sell oversized products with
more than 3 g pseudoephedrine per package
Furthermore, selling or transferring quantities of product to another pharmacy or
retailer is considered wholesaling and will require a license
Importing/exporting of any precursors requires a license
Drugs of abuse
Pseudoephedrine – precursor to crystal meth
Dimephydrinate – large quantities can result in the patient getting a “high”
because crosses the BBB.
Laxatives – weight loss (specifically stimulant)
Anabolic steroids – eg. Testosterone for bodybuilding (SE: testicle atrophy,
gynecomastia, acne
Narcotics – eg oxycontin (oxycodone controlled released), oxycodone, etc.
Controlled substances – eg. methylphenidate, nabilone
Drug disposal
Ontario has a service with community pharmacies, where patients bring in their
expired medications. The pharmacist can send it out to get destroyed, or destroy it
themselves.
Responsible drug disposal
o Medications should never be disposed in a way that would risk harm to
health of public or environment
o Often pharmacies…
Can destroy narcotics and controlled substances the same way as other drugs. But
need permission to destroy these drugs (need it for narcotics and controlled
drugs). Once you receive the letter you can proceed
o If you destroy it yourself you need witness
What is compounding?
Professional pharmacy activity
Based on a professional relationship
Pursuant to a prescription
o You cannot make a compound before a prescription
Customized service (Tailored for the patient)
Not for commercial sale
Regulated by OCP (provincial), provincial guidelines
o REGULATED PROVINCIALLY!!
Pharmacists responsible for prices
Why compound?
Product is not commercially available
Allergic to current drug products available
Discontinued product
o Ex: phenazopyridine
Improve palatability
Veterinarian use
Research needs
What is a compound?
Compounds = preparations = extemporaneous
mixtures = extemporaneous mixture
3 main ingredients:
o Solvents or liquids
o Bases
o Powders or chemicals
What are other ingredients
o Suspending agents, preservatives, buffering agent, chelating agents
o Hydroquinone – reducing agent, for skin
Labeling Requirements
Ingredients
Expiry
o Use shortest expiry out of the ingredients or compounded products
Storage info
Period of stability and safety
Avoid abbreviations
Include lot numbers (on prescription itself, don’t have to on label)
o Want to do this just incase problems come up about original ingredients (a
withdrawal) we can warn patient.
Sterile Preparations
Read on your own
Professional Collaboration
Collaborative Care
• Advantages
o Improves access to care
o Enhance the quantity and safety of care
o Enhance the coordination and efficiency of care
o Enhance provider morale and reduce burnout within health professions
Definitions:
• Practitioners: a person registered and entitled under the laws of a province to
practice medicine, dentistry, or veterinary medicine
o Can dispense medication to their own patients
o Practitioner (limited to just doctor, dentist, vet) vs prescriber (midwives,
ophthalmologist, etc.)
Math
The Basic Process
• Identify the KNOWNS
o Identify the things you know that are important to you
• Identify the UNKNOWNS
o What does the question want you to solve?
• Identify the EQUATIONS, or processes that you can be applied
• Identify the TYPE OF ANSWER
o What units do you need?
o
• SOLVE: using the equations and knowns to get you to your unknowns and
answer
Systems of Measurement
• SI System (International System of Units)
o Metric system – base unit are the meter and the kg
o This is what we use in Canada
• Apothecary Measure
o Predominantly pharmacists’’ system, measures volume – uses ounce,
fluidounce, etc.
• Avoirdupois System
o Widely used in the US for measuring weight – uses ounce or pounds
Aliquot Method
• This is a method of weighting by which small quantities of a substance are
measured within the desired degree of accuracy
• Used when precision of measuring device is not sensitive enough to measure
required small amount of drug
• Dilution of drug by a multiple and then taking a small portion out to get desired
quantity of drug which …
• Weight –
o Most scales have a max capacity of 120 mg, rule of thumb we want to avoi
errors of greater than 5%
o Smallest quantity = 100% x sensitivity requirement (mg)
Acceptable error (%)
• Formally, sensitivity requirement is the load that will cause a change of one
division on the index plate of the balance
• Ex: assume you want to measure 10 mg of drug on a scale, which has sensitivity
requirements of 6 mg on a scale which has a sensitivity requirements of 6 mg and
provides of +/- 5% accuracy. How much diluent needs to be added?
o Answer: 120 mg. Therefore 120 mg is least weighable quantity but you need
10 mg, so how much diluent?
o Dilution factor = least measurable qty / drug required
Factor = 120 / 10 = 12
Final weight = least measurable qt x factor
= 120 x 12 = 1440 mg
Diluent required = 1440 – 120 mg
= 1320 mg of diluent
What this is saying now that if we pull out 120 mg of mix we have 10
mg of drug (120 mg Drug in 1440 total mass = 10 mg of drug in 120
mg total mass)
• Example: assume you want to measure 10 mg of drug on a scale which has
sensitivity requirement of 10 mg and provides accuracy of +/- 5%?
o Answer: Smallest quantity = 100 x 10 / 5. Smallest quantity = 200 mg.
Therefore 200 mg is least weighable quantity
o But you need 10 mg, so how much diluent?
o Dilution factor = least measurable qty / drug required
Factor = 200 / 10 = 20
Final weight = least measurable qt x factor
= 200 x 20 = 4000 mg
Diluent required = 4000 – 200 mg
= 3800 mg of diluent
Some examples
• Prednisone 50 mg daily for 1 week, then 45 mg for one dose week, then decrease
by 5 mg Q3D, until finished. Dispense 5 mg tablets
o Answer: 241 tablets
• A physician wants to switch a terminally ill patient from slow release pain
medication tablets, 15 mg twice daily, to a liquid dosage form of same medication
because the patient has difficulty-swallowing tablets. If liquid contains 5 mg per
ml is prescribed every 4 hours, what volume should be dispensed for a 20 day
supply to provide the same pain relief as the tablet regimen.
o Very important question
o Answer: 120 ml
Example:
• How many grams of hydrochloric acid should be used to in preparing 8
fluidounces of a 5% solution in 70% alcohol?
o Answer: 12 ml
o 8 fl oz = 240 ml
o 240 ml x (5g /100 ml) = 12 ml
• Rosewater solution contains 10% v/v of concentrated peppermint oil. What volume
of concentrate will be contained in 85 ml of peppermint oil?
o Answer: 850 ml
o (10 ml / 100 ml) = ( 85 ml / x) x = 850 ml
• How many grams of a drug substance are required to make 120 ml of 20% (w/w)
solution having specific gravity of 1.15?
o Answer: 27.6 g
o SG = 1.15 = x / 120 x = 138g
o (x / 138 g) = (20g/100g) x = 27.6 g
Ratio Strength
• Usually weak concentration will be expressed in terms of ratio strength – do no tbe
thrown off! This is simply another way of expressing percentage
• Example: how many milligrams of Drug A should be used to prepare the following
solution: Drug A 1:10 000 500 ml sig: as directed
o Answer: 50 mg
o 1 / 10 000 = x / 500 ml x = 0.05 g = 50 mg
Chemotherapy Dosing
• Verification of dose is critical step in chemotherapy admin
• BSA determination is essential for chemotherapy dosage calculations
o We think about site, but also BSA gives you an idea of how big the person is
and distribution of drug. Weight and BSA are essential.
o Often physicians will calculate with BSA and weight and try to go somewhere
in between to make sure they are giving the right one
• The use of a standardized format for determining BSA is needed to ensure optimal
treatment, and can reduce the potential for medication error.
Formulae
(ONLY ONE YOU NEED TO KNOW IS BMI – THEYD GIVE YOU THE REST)
• Lean body weight
o LBW (men) = (1.10 x Weight (kg) ) – 128 [ Weight2/ (100 x Height (m) ) ]
o LBW (women) = (1.07 x Weight (kg) ) – 148 [ Weight2/ (100 x Height (m) ) ]
• Ideal body weight
o IBW (men) = 50 + 2.3 ( height (in) – 60) [Devine formula]
o IBW (men) = 45.5 + 2.3 ( height (in) – 60) [Robinson Formula]
• BMI = weight (kg) / height (m2)
• Creatinine comes from the muscle – someone who is very obese, their muscle does
not change, they have more fat rather than muscle. For someone that is obese, we
don’t want their actual body weight, we take their ideal body weight. Actual body
weight would incorporate all their fat
• When do you dose on actual weight?
o Drugs that are absorbed and get into fat (more lipophilic drugs).
IV Infusions
• Common Examples include
o 0.9% NaCl (NS)
o 0.45% NaCl (1/2 NS)
o 5% Dextrose in water (D5W)
o 10% Dextrose in water (D10W)
o 5% Dextrose in Saline (D5NS)
• Ex: How many grams of Dextrose and NaCl are required to prepare 500 ml of
D5NS for IV infusion?
o Dextrose: ( 5 g / 100 ml ) = ( x / 500 ml ) x = 25 g
o NaCl: ( 0.9 g / 100 ml ) = ( x / 500 ml ) x = 4.5 g
IV Push/Bolus
• Ex: MD orders 3 mg of IVP of a Drug A. Pharmacists has Drug A as IV in 1.5 ml
vial having 0.75 mg/ml of Drug A. Calculate ml of injection required? Calculate
vials he needs to open.
o (3 mg / x ) = ( 0.75 mg / 1 ml) x = 4 ml (needs 4 ml)
o 4 ml / 1.5 ml = 2.67 3 vials
• Ex: In a treatment of a condition X, a drug A is indicated as a bolus dose in range
of 0.2 – 0.4 mg/kg IVP. Assuming patient weighs 150 lbs, calculate the bolus dose
range for patient?
o 150 lbs = 68.2 kg
o Dose range: 13.6 mg– 27.3 mg
Important distinction
• IV infusions sets are pre-calibrated – cannot change the number of drops that make
a ml!! But you can change the drops per minute (the rate)!
• Ex: there are 250 ml of D5W infusing at 33 drops/min on IV tubing calibrated at
10 drops/ml. Calculate the infusion time
o 250 ml x (10 drops/ml) = 2 500 drops
o 2 500 drops / ( 33 drops/ min) = 75.75 min (=1.26 hr)
• Ex: Using an IV pump calculate the duration of 1000 ml of normal saline infusing
at 125 ml/ hour
o Answer: 1000 ml / 125 ml/hr = 8 hours
Alligatoin Method
• Ex: How many grams of hydrocortisone powder should be added to 32 g of 5%
hydrocortisone ointment to prepare an ointment containing 20% of
hydrocortisone?
o 32 g (5 g/100g) = 1.6 g HC
o 1.6 g HC + x = 20g Solve for x. Get x = 6g HC
32 g total + x 100 g
Logic: we know we have 1.6g pure HC in the 5%. We are going to add
X amount of HC to get 20% (20g/100g). The x we add is going to
affect the pure HC, and the total. Solve for x to get 6g
o Other way to do it: the tic-tack-toe method
50 5 + 20
20 25 25
5 25
o 25:25:25 1:1:1
Examples:
• Non-electrolyte eg. Boric acid has Mol Wt of 61.8 g/mol. How much boric acid is
required to make 1000 g of water solution isotonic?
o Mole of anything in 1000 g of water get a freezing point of – 1.86 C
o 1 mole of this is = 61.8 g
o Freezing point will change proportionally. If we put less than 1 mole, freezing
point will rise. Use proportions!
o Isotonic = - 0.52
o – 0. 52 / - 1.86 = 0.279 (Always for non-electrolytes! )
Simplified formula: Grams of substance = MW x 0.28
o 0.279 x 61.8 g = 17.28 g of Boric Acid
• Non-electrolyte substance B has Mol Wt of 90.3 g. How much substance B is
required to make 100g of water solution isotonic?
o MW X 0.28 = 90.3 x 0.28 g = 25.28 g (but this is for 1000g of water)
o So for 100g of water (divide by 10) = 2.53
o Electrolytes
Grams of substance x (i) = 0.52 degrees C
Molecular weight of drugs 1.86 degrees C
NaCl Equivalent
• Compounds may involve multiple ingredients and therefore a standard reference
point is required to express isotonicity across ingredients
• This is called NaCl equivalent calculated as
o (NaCl M.W) / ivalue of NaCl
(X M.W) / ivalue of x
• Amount of NaCl that is equivalent to 1 g of solute/drug
• What does this mean? If we are calculating isotonicity of a certain solution and the
amount that we need to use of a drug is toxic, then we can just use the amount of
drug we want, and then make the solution isotonic with NaCl.
NaCl Equivalent
• General procedure to calculate tonicity:
1. Calculate the amount of NaCl (in g) represented by the ingredients in the
prescription. Multiple amount of each substance by its NaCl equivalent (E).
2. Calculate amount of NaCl (if used alone) that would be contained in an
isotonic solution of the specified volume in the formula given, ie, amount
of NaCl to make a solution isotonic is 0.9% w/v (0.009 g/ml)
3. Subtract the amount of NaCl in STEP 1 from STEP 2. This amount
represents the amount of NaCl that would need dto be added to the solution
to make it isotonic
4. If an agent other than sodium chloride is to be used to make the solution
isotonic, divide the amount of sodium chloride by the NaCl equivalent of
the other substance.
• Ex: How many grams of NaCl should be used in compounding the following
prescription? (NaCl equivalent of ciprofloxacin = 0.23)
Rx Ciprofloxacin HCl 0.5 g
NaCl q.s
Purified water ad 30 ml
Make isotonic solution Sig: for the eye
o Question is asking how much more nacl do you need to make the entire
solution isotonic. We need 0.5 g of cipro (0.5g/30 ml – therapeutic
concentration)
o Qs – it’s telling you to add in some amount of NaCl to make solution isotonic
o E-value = 0.23 this means 1 g cipro = 0.23 g NaCl
o Convert the drug to an equivalent amount of NaCl
0.23 g NaCl = x x = 0.115 g NaCl equivalent
1 g cipro 0.5 cipro
o Total volume to make whole solution isotonic
30 ml x (0.9 g / 100 ml NaCl) = 0.27 g NaCl
o Difference is how much NaCl you need to add
0.27 g – 0.115 g = 0.155 g NaCl
o Therefore you need to add 0.155 g of NaCl.
• Determine the volume of purified water and 0.9% w/v of NaCl solution needed to
prepare 30 ml of a 1% w/v solution of hydromorphone hydrochloride (E= 0.22)
o Hydromorphone 1% w/v in 30 mls 0.3 mg of Hydromorphone
o 0.3 mg x 0.22 (evalue) = 0.066 g NaCl Equivalent
o 30 ml total – must be 0.9% NaCl
therefore, 0.9g / 100ml = x / 30 ml ; x = 0.27 g NaCl
o 0.27 g – 0.066 g = 0.204 g NaCl needed
NaCl is provided in NS (0.9% NaCl solution so have to convert to mls
of solution). 0.204 g / (0.9 g/100ml) = 22.67 ml NS
o Total volume we need is 30 ml
30 ml – 22.67 ml = 7.33 ml
o Answer: 22.67 ml of NS ; 7.33 ml Water
Milliequivalents (mEq)
• A chemical unit, the mEq, is used to express the concentration of electrolytes in
solution
• This unit of measure is related to the total number of ionic charges
What is an “Equivalent”
• Equivalent: an equivalent is an amount of material that will release or react with
Avagadro’s number of electrical changes on particles like OH1-, H1+ of electrons
• This means that an equivalent of HCl will react with a mol of hydroxide ion
change
“Equivalent”: Example
• 1 mol Ca(OH)2 = 2 equivalents Ca(OH)2
• there are TWO OH1- released when the hydroxide dissolves
• the calcium hydroxide releases Ca2+ and two OH1- ions
• the equivalent weight of calcium hydroxide is ½ the mass of a mol of calcium
hydroxide
• 1 mol Ca(OH)2 = 74 grams Ca(OH)2; 1 equivalent Ca(OH)2 = 37 grams Ca(OH)2
“Equivalent”: Example 2
• 1 mol H3PO4 = 3 equivalents H3PO4
• there are THREE H1+ released when the hydroxide dissolves
Milliequivalents
• a milliequvalent is 1/1000 of an equivalent
• This means an equivalent is 1000 mEq, in terms of g the equivalent weight is equal
to 1000 mEq weights
• Example:
o 1 Eq H3PO4 = 1000 mEq H3PO4
o 1 Eq mol H3PO4 = 32 g H3PO4
o 1 mEq mol H3PO4 = 32 mg H3PO4
Electrolyte Solutions
• Milliequivalents
o mEq = mg x valence / (atomic or MW)
o mg = mEq x atomic or MW / valence
• Millimoles
o A mole is a molecular wt of a substance
o Mmol is 1/1000 of MW in grams
• Milliosomes
o Key difference is no of species
o Looking at what it dissociates into
NaCl: 2 species – Na and Cl
o mOsmol/ L = wt of substance (g/L) x species x 1000 / MW
o Ex: Calculate mOsmol of 0.9% NaCl if the MW is 58.5g?
mOsm/L = 9g/l x 2 x 1000 / 58.5
mOsm/L = 308
How many mmols do I have? Divide by 2, only thing that changes is
species.
o Ex: Calculate mOsmol of 10% anyhydrous if the MW is 180g?
mOsm/L = 100 g/l x 1 x 1000 / 180
mOsm/L = 556
o Ex: what is the concentration in mg/ml of a solution containing 3 mEq of KCl
per ml (MW of KCl = 74.5). what is weight in %w/v?
Use – mEq = (mg/MW) x valence
223.5 mg/ml
22.32%
o Ex: what is the concentration in g/ml of a solution containing 5 mEq of
CaCl2. 2H2O per ml (formula wt = 147). What would it be in %q/v?
36.75%
Pharmacokinetics and Dynamics
Important Concepts
• Pharmacokinetics
o Study of drug ADME - absorption, distribution, metabolism, and elimination
• Bio-availability
o Relative amount of drug from a given dosage form entering systemic
circulation
OR
o Measurement of rate and extent (amount) to which the drug is available at the
site of action
o Relative bioavailability
Systemic availability of the drug from a dosage form as compared to a
reference standard given by the same route of administration
o Absolute bioavailability
(F) is the absolute fraction of drug systemically absorbed from the
dosage form
F = AUC (oral) / AUC (IV adjusted for dose)
o Bio-equivalence
The rate and extend of drug absorption between two different mfg or
different dosage form. If it falls within limit, it is considered bio-
equivalent.
If 2 products (generic vs. RLD- referene listed drug product) are
pharmaceutical equivalents and rate and extent of systemic drug
absorption do not show statistically significant difference …
o Area under the curve
The blood drug conc. Vs time curve …
o Volume of distribution (Vd):
Is only hypothetical and not real
It is the volume required to distribute drug so that the same conc as
found in the blood can be achieved
It is important indicator of drug’s extend of distribution in body fluids
and tissues.
Low Vd indicates drug is confined to blood, high indicates vast
distribution in peripheral compartment, and stored in body fats, bound
to tissues.
Vd = D/ Cp. D = Drug in body; Cp = Drug’s plasma concentration
o Elimination half life
Time taken by drug plasma conc (as well as the amount of drug in the
body) to fall by one half
T1/2 = 0.693 / k, where k is elimination rate constant
T90% = 0.105 /k
This is for a drug that follows first order kinetics! (Meaning that for
every amount of time that elapses you lose a certain amount of drug by
the body).
In first order, drug cleared from body is dependent on the amount of
drug at that time.
o Important formulas – you are given these, just have to know what they mean!
D = Vd x Cp
DL = Css x Vd
• DL – loading dose
Css = R / (Vd x k)
• Css = concentration at steady state
R = rate of infusion; k = elimination constant
Questions
• A specific dose of drug X is given q6h until steady state levels are reached. At
steady state, the AUC for one dosing interval is 72 mg/L/hr. what is the average
concentrations over that interval?
o Every 6 hours they give 72 mg/L/hour. So if (72 mg/l/hr) / 6 hr = 12 mg/l
With this we are assuming that 72 mg is given every 6 hours. And that
the 72 mg dose elapses over 6 hours equally. So 12 mg/l concentration
is released each hour.
Css = AUC / T
Css = 72 / 6 = 12
• If the bioavailability factor (F) for a drug substance in a dosage form is 0.50, how
many milligrams of drug would be available for absorption from a 100 mg tablet
of a drug.
o F = 0.5 – meaning 50% is cleared, 50% absorbed
o 100 mg tablet 50 mg available for absorption PO
• If the bioavailability of Drug A in a 0.5 mg tablet is 0.60 compared to the
bioavailability of 0.75 in a liquid form (0.05 mg/ml), calculate the dose of the
elixir equivalent to the tablet.
o Tablet 0.5 mg – bioavailability 0.6 get 0.3 mg with every dose
o Elixir 0.05 mg/ml – bioavailability 0.75 0.0375 mg/ml
o We need to take 0.3 mg of drug, therefore
0.3 mg / (0.0375 mg/ml) = 8 ml
o We need to take 8 ml of the elixir
• If the AUC for an oral dose of a drug administrated by the tablet is 5 ug/ml/hr, and
the IV dose is 12 ug/ml/hr, calculate the bioavailability of the oral dose of the drug
o 5 / 12 = 0.416
• A patient received a single IV Dose of 400 mg of drug x that produced an
immediate blood concentration of 8.0 ug of drug per milliliter. Calculate the
apparent volume of distribution
o IV dose = 400 mg, blood concentration = 8.0 ug/ml
o C0 = D /Vd
8 = 400 / Vd
Vd = 400 / 8
Vd = 150 L
o Should convert mg to ug. And then ug/ml to ug/L but end up crossing out in
this case
• 12 hours following the IV administration of a drug, a patient weighing 80 kg was
found to have a drug blood level concentration of 10 ug/ml. assuming the apparent
volume of distribution is 10% of body weight, calculate the total amount of drug
present in body fluids 12 hours after the drug was administered.
o Pt wt = 80 kg; C = 10 ug/ml ; Vd = 10% of 80 kg = 8 L
o C0 = D /Vd
10 = D / 8
D = 80 g
o Should convert ug/ml to g/L.
• Drug A has been administered to a patient weighing 80 kg. determine the half life
of a Drug A whose volume of distribution of 0.5 L/kg and gives a clearance of 5.1
L/h
o Wt = 80 kg; t1/2 = ?; Vd = 0.5L/kg *80 = 40L; Cl = 5.1 L/h
o K = Cl/ Vd
K = 5.1 / 40
K = 0.1275
o T1/2 = 0.693 / k
T1/2 = 0.693 / 0.1275
T1/2 = 5.43
• Determine rate constant for drug A following first order kinetics, when
administered initial concentration was 50 mg/dL and after 5 hours the
concentration was determined to be 35 mg/dL
o Get answer from Nada
Management
Why do we open up a pharmacy?
• Patients
• Money!
• Self-fulfillment (satisfaction in what you do)
• Greater “control”
• Innovative pharmacy systems development
o A lot of pharmacists have great ideas to move away from technical duties to
better save the patient in new ways. They are playing a bigger consultative
role.
Managerial Mistakes
• These are things that a pharmacy manager should not do
o Failure to delegate
o Failure to keep learning
o Lack of accountability
o Lack of knowledge of the business
o Lack of vision
o Can’t build teams
o Failure to make decisions
Business Structures
• Is there a better form out there?
o Every structure has pros and cons – depends on situation
• What about for a community pharmacy?
• How do you determine what structure is best for you?
o Owner’s Needs
o Legislature
o Etc.
Sole Proprietorship
• Legally, the owner (proprietor) is the same as the business (one in the same)
o Therefore, there’s UNLIMITED liability
• Responsible for all debts and obligations
o Therefore a creditor can make a claim against your assets (personal or
business)
• Pros
o Easy and inexpensive to start
Only need to register the business name provincially
o Dicrect control – autonomy
Deciions
o Less working captal needed
You need less money to start because it is easier to start
• Cons
o Unlimited liability
You and the business are one
Have to use personal assets to pay off business debts, if needed
o The profit from business, if goes towards personal income, taxed at a higher
rate
If you are taxed as a cooperation you pay less than income
o Lack of continuity
Succession plan – if you are the sole proprietor you will have to find
someone to pass it onto, sometimes difficult.
Partnerships
• Good option if you want a partner, and you do not want to incorporate yourself
• Easier to raise funds
o Combined financial resources
• Partnership agreement
o Can stipulate whatever you want
• Get a share of the profits
• 2 types of partners: general and limited
• Limited liability partnerships (LLP)
o Don’t have the same control and privileges as a general partner, but only
liable to the amount they invested
o They also don’t have as much say – cant tell anyone what to do
• Pros
o Easy to start, relatively
o Can distribute or share the costs with your partner
o Profits go to owners
o Can have equal share in profits/assets
o Better tax rate
o Easier to manage
• Cons
o Unlimited liability (just like in sole-proprietorship)
o Hard to find the perfect partner!
o Financially you’re labile
o More complex to dissolve
Corporations
• To “incorporate” yourself
• Done on federal or provincial level
• The business (or corporation) is a separate legal entity
o Separate from the owners/shareholders
• As a shareholder, you are not liable personally
o Don’t have to use personal assets
• Can be public or private
o Crown? A corporation owned by the government
• Can be the big or small scale
• Pros:
o Limited liability!
o Can transfer ownership
Shares
o Easier to continue the lie of the business
o Separate legal entity
o Ease of raising capital
o Tax advantage
o Attract specialized skills and management (because they are established
people come to them)
• Cons
o More regulations
o More expensive to incorporate
o Complicated to start and regulated
o Conflicts between shareholders and board of directors
Have to please the shareholders
How can this affect community pharmacy?
• If the decisions are made by non-pharmacists it may not be for
the best interest for the pharmacist
Cooperatives
• The business is owned by its members
o An association
• Least common form
• Appropriate when you want to pull all your resources in the same “pot”
o Common needs are fulfilled, like delivery, sale and employment
o Happens a lot in agricultures
• Managed by a board elected by the members
o Example in pharmacy? Pharmasave
• Pros:
o Owned and controlled by its members
o Voting system (one member = one vote)
o Limited liability
o Profits are distributed amongst members
• Cons
o Conflict between members
o Decision-making process can be longer
o Need the members to participate
o Profits are distributed
o May feel less incentive to reinvest back into the cooperative
Franchise
• The company gives you the right or a license, to run a business under their name
(brand)
• These are established operating rules and methods
• There’s a fee (royalties)
• It’s a style, not a form of ownership (you don’t own the company)
• Pros
o Provides resources (the company does the work for you)
Site, lease negotiation, design, pricing, policies and procedures, buying
power (bulk), monitors inventory as well
o Can rely on an established name and reputation
o Customer recognition
o Access to consumer data and research
• Cons
o The fees!
o Lack of proper support from the franchisor
o May be forced to pay for promotional material or activity
o Forced to take on reputation of other locations
o Intrusion
Importance of records
• Provides information
o Progress, ups or downs
o Catch and fix the problem before it gets worse
• Banks and lenders want information
o To help decide whether to lend or not
o If you’ll be viable enough to pay back the debt
• Tax purposes
• Auditing
• Valuation of practice
o Value of the pharmacy (need it if you’re selling)
Financial Statements
2 important ones:
Balance Sheet
Income Statement
Balance Sheet
• Basically picture of the financial position of a business in a point in time
o At a particular date
• Snapshot of the assets, liabilities and owner’s equity accounts
• Fundamental equation:
o Assets (A) = Liabilities (L) + Owner’s Equity (OE)
• Owner’s Equity – the personal …
Balance Sheet: The low down
• Assets: Cash, accounts receivable, inventory, etc.
• Liabilities: accounts payable ,loans, notes payable,
Fixed/ Current Assets and Liabilities
• Fixed assets
o Hard assets, eg equipment, furniture, etc.
• Current assets
o What you own and expect to own in 12 months
• Long term liabilities
o Debt which take > 12 months to pay
• Short term liabilities
o Must be paid within 12 months
Working Capital
• = current assets – Current liabilities
Income statement
• shows the change in retained earnings from one balance sheet to the next
• shows profit earned and contribution to owner’s equity.
Inventory Management
• Involves systems and management in place to control, regulate, adjust and protect
inventory
• Have to maintain all levels of merchandise and goods
o Pharmacy, front stores, beauty, food, etc.
• Purchasing, receiving, stock, tracking protocols
• Returns
• Destruction and disposal
• Forecasting (Ex: long weekend, know you cant order for longer so order more to
be prepared – drugs people will NEED)
• Inventory control and audit
Taking Inventory
• PHYSICAL inventory is done on a scheduled basis (at least once a year)
• Pre-printed stock lists with price per unit are used record the actual counts
• The value of inventory is determined by multiplying the price x count per unit.
• Process is audited by accounting firm
Inventory Turnover
• A quantitative measure, to see how well you are managing yur pharmacy inventory
• Basically, how many times, in a specified time, frame is yur total inventory (all the
drugs in your pharmacy, on your shelves) is replaced (so a rate)
o Often over the course of a year
• Turnover = relationship between cost of drugs (goods) sold and inventory)
• TO = Cost (of goods sold) / Avg. Inventory (at cost)
o Cost – found on income statement
o Avg Inventory– find average of the beginning inventory and ending inventory
of the time period (ie. Past year)
• What is the ideal TO rate?
o Is it good to have a high TO rate, like (10-12)per year? NO! Means you keep
having to order
o Is it good to have a low TO rate, like (2)per year? NO, means stays on your
shelf too long
o Ideal is 4 (can go a bit higher 4-6)
Hospital Management
Important to know what hospital pharmacists do:
• Medication experts within the multidisciplinary health care learn
• Have access to patient-specific information, such as laboratory test result and
diagnosis
• Have access to colleagues to share info/expertise
• Document their activities and findings in the patient’s health record (progress
notes)
Hospital pharmacists
• Provide care in a variety of settings and specialties
• Long-term care services
o Complex continuing care
o Geriatrics
o Palliative care (end of life)
o Rehabilitation (post-surgery)
• Outpatient services
o Asthma management clinic
o Cancer care
o Home care
o Renal dialysis
o Diabetes clinic
• Preventative and health promotion services
o Immunization, etc.
• Other services
o Drug use evaluation (DUE)
Evaluates benefits, risks, cost, research behind drug on a global level.
o Medication reconciliation
“Best Possible Medication History” (BPMH)
o Provision of drug info
Doctors can call in and speak to these pharmacists for dosing, etc.
o Research
Role of Hospital
1. Patient Care: involves the diagnosis and treatment of illness and injury,
preventative medicine, rehab, etc.
2. Education: educating staff to provide better care, patients to are for their ailments
and educating HCP’s in order to train them to be competent professionals
3. Research
4. Public Health Promotion: assisting the community in reducing the incidence of
sickness and to increase the wellness of the population
Pharmacoeconomics
• Use this to make decisions
Hospital Organization
• Complex organization structure similar to business corporation
• Board of trustees, comparable to Board of Directors, governs the hospital
• The broad is the executive body of the hospital and is responsible for the
establishment of the hospital’s by laws and policies
• Medical Advisory Committee (MAC)
o Appoints various medical staff to other standing or special committeees which
report directly to the MAC
o Eg. P&T committee, Quality Assurance committee, etc.
• Pharmacy and Therapeutics Committee (P&T)
o Formal line of communication between the medical staff and the pharmacy
department of hospital
o Usually composed of at least 3 physicians, a pharmacists and a rep of nursing
staffs
o Role of committee
1. Evaluates and standardizes medication use within the hospital
2. Sets standards for drug use
3. Evaluates the ongoing use of drugs for effectiveness
4. Maintains the hospital formulary
• Recommend drugs to be added to the formulary
• DOESN’T decide – MAC does this!
Important Because
• Increasing costs of providing the service as well as the cost of drugs
• Increasing demands for accountability including risk management and patient
safety
Statistics
• ADR rate – many preventable, main causes of ADR’s
• Drug costs
• Health care expenditures
• Total health expenditure by use of Funds, in Canada
o 1. Hospitals
o 2. Drugs
o important!
Definitions
• Adverse Drug Reaction (ADR)
o Any noxious, unintended and undesired effect of a drug which occurs at doses
used in humans for prophylaxis , diagnosis or therapy
o Excludes: therapeutic failure, intentional/accidental poisonings, drug abuse,
medication errors in administration (too much/little drug), drug interaction,
noncompliance
• Adverse Drug Event (ADE)
o ADR in addition to medication errors (errors in prescribing, dispensing,
patient adherence, and monitoring)
Workload Measurements
• Drug Distribution
o Raw counts – number of drugs dispensed
o Standard time measurements
• Clinical Activities
o Raw counts – med recs, pt counseled
o Actual time counts
o Management tool around resource allocation
• Should provide the following information
o The workload demands placed on the pharmacy department
o The amount of time (input) spent on various department activities
o The index of pharmacy productivity
o The optimum number of employees that are needed in the department
Pharmaceutical Calculations:
rd
3 Part Reimbursement and Claims
How do people pay for their drug?
• Out of pocket (cash)
• Insurance plans or 3rd party plans
o Is the government plan also a kind of insurance plan? Yes
o Private vs public
Important Concepts
• Plan sponsor
o A group that is covering the cost of the insurance or health plan
o Ex: a company or employer
• Plan member
o The patient or individual who gets these benefits
• Plan administrator
o The insurance companies which are chosen by the employer, eg. Manulife,
Sunlife
o Companies contract out to these administrators for insurance
• 3rdParty Reimbursement
o Copay
o Deductible
o Professional fee cap
o Total yearly cap
• What is a “claim”?
o What the member sends for reimbursement to insurance plan (ex: prescription,
receipt from dental care, etc.)
o Usually done electronically or manual submission via mail
• Co-pay or co-payments
o A portion/percentage of amount that the cardholder needs to pay along with
third party
o Usually a fixed amount
o Co-pays are there to make people more cautious. If prescriptions were
completely free, people would be more likely to be wasteful with the
prescriptions they get
• Deductible
o An amount that needs to be paid by cardholder before benefits get
activated/kick in
• Professional fee cap
o Third party puts a cap on max. professional fee it will pay. Beyond that
cardholder needs to pay
• Total yearly cap
o The maximum dollar value per year that third party will cover. When
exceeded, cardholder needs to pay the exceeding amount
Other information about insurance plans
• Usually cover the generic drug
o May cover the brand, if the prescriber does what? Only will cover the brand if
the doctor demands no sub
o Most cases however, the patient pays the difference between generic price and
brand price, if they want the brand drug
• Most plans do not cover “life style drugs” (weight management, erectile
dysfunction, smoking cessation, etc.), NHPs, vitamins, OTCs, herbals
• Usually, the max supply a person can get at a time is 100 days worth of a
medication
Calculations
• Mr. XY brings in a new prescription to Pharmacy. The cost of the Rx is $150. It’s
a first Rx of the year for patient. The plan benefits kicks in after payment of $100
deductible. The plan pays 90% of the cost of Rx. What would be the amount
payable by XY on this prescription?
o Cost of Rx: $150. Deductible (paid by patient) = $50: amount for which
coverage applies
o 90% coverage: 50 x 0.90 = $45
o Copay = $50 – $45 = 5$
o Total payable: $100 + $5 = $105
• If there is no deductible to be paid, how much is XY paying for his rx?
o Paying 10% of $150. $150 x 0.10 = $15
• After a month, Mr. XY comes to pick up the refill and the cost is the same, $150.
How much does he pay?
o $15! (Same as question before)
• There is a change in 3rd party plan. Now, they introduce $5 professional fee cap. If
the new Rx is $150 which includes $10 professional fee, how much would Mr. XY
be paying for his Rx?
o $10 professional fee: $150 - $10 = $140 (Patient has to pay $5, because
insurance will only cover $5)
o 90% coverage, so patient pays 10%: $140 x 0.10 = $14
o Total payable: $14 + 5 = $19
• By December, Mr. XY bought drugs worth $4800 the plan has cap of $5000 per
year. The next Rx he brings costs $800 including cost of professional fee of $10.
At 90% coverage, how much money he has to pay for this coverage?
o $800 - $10 (professional fee) = $790 (cost of Rx)
Patient pays $5 of professional fee (of the $10 fee)
o Plan will cover 90% of $200 (to reach $5000 cap), patient pays 10%:
$200 x 0.1 = $20
$790 - $200 = $590 (amount untouched by insurance)
o Total payable: $590 + $20 + $5 = $615
Medication Safety
Adverse Reaction (AR)
• What is it?
o Unintended and undesirable effects secondary to health products (drugs,
medical devices, natural health products)
• Could cause hospitalization, malformations, disability, or death
• Post-market surveillance is required based on Food and Drug Act and Regulations
• How are ARs detected?
o Patients, health care professionals, manufacturers, regulatory bodies
o Reporting
Voluntary reporting
Post-marketing surveillance by manufacturers
o MedEffect Canada for reporting ARs (IMPORTANT! KNOW IT!)
By consumers, industry, professionals
Via fax, online, telephone
More information found in the CPS (appendix)
Sole purpose is for dealing with ARs
• What if...
o A mistake happens, even if nothing happens should address it.
o A mistake happens but no one notices?
A Team-Based Process
• Multi-disciplinary process
• Those with direct knowledge of the event processes
• Those responsible for change
o Meaning, those that can impose a change or have an impact on the way we do
things (the manager/owner)
Multi-disciplinary Approac: key benefits
• Detailed exam by team often discovers new info not previously known
Safety Strategies
• Eliminate Remove the hazard
• Control Provide safeguards
• Accept
o Not an option! If a serious hazard is identified, the minimum strategy is a
controlled measure
FMEA Steps
1. Select process and assemble team
2. Diagram the process
3. Brainstorm potential failure modes and determine their effects
4. Identify the cause of failure modes
5. Prioritize failure modes
6. Redesign the processes
7. Analyze and test the changes
8. Implement and monitor redesigned processes
Evidence Based Medicine
Evidence Based Medicine (EBM)
• What is it?
o Interaction of best research evidence with clinical expertise and patient values
• Why is it important?
o We have a daily need for valid information
o Traditional forms of information has limitations
Traditional forms – books. Information is not updated quickly enough.
Practice changes constantly
o With experience, we rely on judgment so we need the most up to date
information
Sources of Evidence
• Evidence Pyramid (in increasing importance of clinical decision making)
o Case Reports
o Case studies
o Cross-sectional surveys
o Case control studies
o Cohort studies
o RCTs
o Meta-analysis, systematic Review
• As we go down confidence, robustness, power of study increase
Sources of Evidence
• Systematic Review
o Formal method to review articles in literature on a particular topic
o Published and unpublished trials
Unpublished trials may have shown drug in a negative light, important
to include. We don’t care about companies, we want to be thorough.
Pubmed is based in North America. M-base has studies outside North
America. We want studies outside of the country we are talking about.
Consider interviews with the publisher of study, they’ll mention things
they did or did not do in the trial
o Reproducible, summaries
o This is the most robust and powerful analysis you can get!!
• Meta-analysis
o Combines several randomized control trials (RCTs) to derive a single
numerical estimate of the result)
Different journals will do different studies, we want to make sure
baseline characteristics are the same. If you have 10 different RCTs
that had the same control, trial, etc. we can combine them
Why would we do that?
• Increase sample size. When we do that it lowers variability. It
also increases representation of population.
• More robust and more powerful. In the end we have a single,
numerical estimate. This is a quantitative estimate
• Practical reason: instead of going through ten separate RCTs,
we go through one meta-analysis.
• Randomized Control Trials
o Gold standard
o Ideal for assessing relative effects of drugs
Very simple – 1 drug, 1 group, 1 control, outcome and measure it.
Tells us if it works or not.
o Have control and treatment groups
Randomized! Decreases bias! Not just by chance that this drug is safe
• Cohort studies (cohort – group with similar characteristics)
o Observational, over long periods of time
o To detect complications, new events
o Follow 2 groups and observe
One with drug, one without drug
o PROSPECTIVE (looking into future!)
This is a good way to assess risk factors! If one group has higher
incidence of a disease, side effect, etc. then we can look at what was
different with that group
• Case Control Studies (not randomized – subject to bias)
o Selecting patients with a specific disease
o Looking at past data to determine causation
o Takes shorter time period to complete
o RETROSPECTIVE studies
Ex: hospital admin looking at everyone that died of sepsis. Look at
records, chose patients based on cause of death, and see what is going
on.
• Case series and Case Reports
o Case series – group of people. Case report – one person
o Case report – detailed report (diagnosis, sign symptoms, disease, treatment,
etc.) on one single patient.
Only used for rare diseases, things that happen one in a million
Sources of Error
• Selection of study participants
• Classification and measurements
• Comparison and interpretation
Bias
• Bias = a prejudice or preconceived notion about what should happen
• Different sources of bias
o Selection bias
o Publication bias (most difficult to overcome)
• Systemic reviews: publication bias is the most difficult type of bias to overcome in
this study design
Results
• P-Value
• Confidence Interval (CI)
• Absolute Risk Reduction (ARR)
• Relative Risk (RR)
Relative Risk Reduction (RRR)
• Number Needed to Treat (NNT)
P-value
• P-value = statistical significance
• P < 0.05 – indicates a true difference between the 2 arms: indicates a statistically
significant result
• The smaller the P-value the more likely the result is not due to chance
• P > 0.05 = no difference between the 2 arms; any difference may be due to chance
Confidence Interval
• Validity
• CI = the precision of the results
o Used with ARR, RR, RRR, and NNT
• The wider the CIs, the less precision there is in the results
• Practitioner must decide if it is clinically significant
Null Hypothesis
• To test whether a pattern exists in a set of data, you propose a NULL
HYPOTHESIS that the pattern does not exist
• (1) Assumption where an observed difference between two samples of a statistical
population is purely accidental and not due to the treatment
• (2) The hypothesis to be investigated through statistical hypothesis testing so that
when argued against, it indicates that the alternative hypothesis is true
• Meaning:
o We accept the null when the P-value is >0.05. If null is accepted, results is not
statistically significant, meaning drug does not do that, it is by chance
o if we reject the null hypothesis, we accept the alternative, meaning drug
works!
Medline
• U.S. National Library of Medicine (NLM)
• Database of citations and abstracts in various fields
• Major source of biomedicine information going back to 1950s
• Broad subject coverage
o Biomedicine and health
o Life sciences for biomedical practitioners
• North American emphasis; majority English language publications
• Available in 2 interfaces
o PubMed (more up to date and free!)
o Medline Ovid (easier to search, subscription)
• Are PubMed and Medline separate?
o NO! Medline is part of PubMed
PubMed
• Gives free access to Medline
• National Library of Medicines (NLM) interface to Medline
• Links to full-text articles
• Search filters for Clinical Queries and Special Queries
• Free service maintained by the National Center for Biotechnology Information
(NCBI)
EMBASE
• Comprehensive online database
• Provides data from outside of North America
• Provides articles not found on Medline
• Biomedical and pharmaceutical information (excellent for drug literature)
• Product by Elsevier (science and health information publisher)
Clinical Evidence
• International source of data for decision making
• Under the British Medical Journal
• Summarizes current knowledge and uncertainty about prevention and treatment
• Based on searches and appraisals of systematic reviews, RCTs, observational
studies
Micromedex 2.0
• By Thomson Reuters
• Evidence based clinical reference
• Comprehensive information (concise and detailed information)
• Good information on pharmacology, mechanisms of action
• Drug, disease, toxicology, patient information
• Mobile application
• Easy to search database
• Not a secondary database per say, but is great database
Examples of Tertiary Sources
• CPS
• Martindale
• USPDI
• Therapeutic Choices
• Patient Self-Care
• e-Therapeutics+
o Electronic data based on CPhA
o Based on information published in the Therapeutic Choices (tertiary)
o Main resources
Therapeutics
e-CPS
Drug interactions
Information for patients
What is e-CPS?
• Web access to CPhA’s CPS
• Current, up-to-date information
o CPS physical book is published once a year
• Health Canada health advisories
• User-friendly search (faster!)
• Information for patients
o Printable sheets
o Supplements counseling
• Also maintained by the CPhA
• Becoming a more important guideline, and increased ease of use (electronic)
• Contents
o Drug monographs
o CPhA Drug Monographs
Complied by the editorial staff of CPhA and reviewed by the CPS
Editorial Advisory Panel (contain information different from that
found in Health-Canada-approved product Monographs)
o Drug Updates
Highlights information on new and revised products available in
Canada
• Clinical Info (Clin-Info)
o Calculations and dosing tools
o Monitoring tools
o Drug use guides (dentistry, pregnancy, breastfeeding, etc.)
o Drug Interactions with foods
o Ingredients
Ethanol, gluten, lactose, peanut oil, soybean, tartrazine
• Directories (similar to physical CPS)
• Product Identification Tool
o Can choose from drop down options
o Eg. Dosage form, shape, color, imprint, scored, etc.
• Glossaries
o Latin Prescription Terms
o Medical Abbreviations
e-Therapeutics
• Easy and fast!
• Up dated information
o Highlighted in different color (green) and font
• Divided in topics
• Provides easy to browse information
• Based on tertiary TC source
USPDI
• United States Pharmacopoeia Dispensing Information
• Two volumes
o Volume I drug information for health care professionals clinical
information (similar to the CPS): American information!
They have on and off label use (for American and Canda)
o Volume II “Advice for the patient”, not intended for health care
professionals, helpful for counseling on prescription drugs
• When to use USPDI Vol. II
o When you want to look up lay language terms and lay languge counseling
points for drugs
o “EASY TO understand” language
Guidelines
• Why do we have them?
o We’re striving for “quality healthcare”
o Effective, efficient, accessible, patient centered, fair, safe health care
o There are clinical gaps we have to fill
o Eg: suboptimal treatment of dyslipidemia, rheumatoid arthritis; improper
control of diabetes; overuse of benzodiazepines
Other references
• Drugs in Pregnancy and Lactation
o Briggs, Freeman, Yaffe
• Pediatric Dosage Handbook
o Taketomo, Hodding, Kraus
• Drug Interaction Facts
o David S. Tatro
• Stedman’s Medical Dictionary for the Health Professions and Nursing
Rx Files
• Academic detailing for heath care professionals
o Academic detailing – a look at all medications by topic!
• Based in Saskatoon, Saskatchewan
• Evidence-based and clinically relevant drug comparison charts
• Good, concise, practical information
• Supplement to learning from TC
Next few don’t have to worry about and know as well as previously stated …
They are not REFERENCES!
DIRC
• = Drug Information and Research Center
• Pharmacist operated (run by the OPA)
• Annual subscription
• Call in drug information questions, where you have a live agent looking up the
answer for you
• Also access to online databases, resources, etc.
Other References
• Health Canada (website)
• “Manufacturer’s leaflet” vs. Drug Monograph
• Canadian Pharmacist’s Letter
• Canadian Pharmacists Journal (CPJ)
• Pharmacy Practice
• The Merck Manual
• Remington
• Natural Medicines Comprehensives Database
• Compendium of Self-Care Products
“Manufacturer’s Leaflet”
• Often, the information included in boxes or bottles of medication
o Often meant for pharmacists to give to patients
o Eg. Yasmin, Crestor, Xalatan, Lipitor, Nasonex, etc.
• Not really considered a resource or reference
• Often a supplement to pharmacist counseling and intervention
o Eg. Directions of use ,common side effects, etc.
• Manufacturer’s leaflet vs. Drug Monograph (by manufacturer)
Pharmacy Practice
• Publication through Pharmacy Gateway (online source of pharmacy publications)
• Rogers Publishing product
• Information on diverse clinical, business, management topics for bot h community,
hospital and industry
• Offers CE lessons
• More for continuing education, rather than a reference
Documentation
Why Document?
• To meet documentation standards that exists for all patient care practitioners
• To be effective and efficient at caring for the patients
• Limit legal liability
• Obtain reimbursement
• Communicate with the patient and the patient’s other care providers
• Present patient cases for learning purposes and to have clinical experience on
which to reflect and convert to clinical knowledge
• Manage a practice
How Do We Document?
• There are two forms by which we document
o Paper documentation
Advantage: efficient
Disadvantage: time consuming to maintain, difficult to retrieve the
information, access
o Electronic documentation
Advantages: more effective and efficient, retrieval is easy, access
Disadvantages: takes time to learn the system
• Unstructured
• Structured
o SOAP
o FARM
Documentations
• Regardless of where and what you are documenting the skills required are the
same
o Be timely
o Be precise
o Be concise
o Be complete
Study Tips
TC
• Goals of therapy – important (understanding it will help you understand tx)
• Clinical investigation – not important (just understand some of the main markers
or clinical signs/measures for specific disease. Ex: HIV – CD4+, viral load)
• Non-pharm – important to understand, should recall 1-2
• Pharm – most important part!! Understand different options in detail!! Know the
pros and cons of each drug, when will you use which, drugs place in therapy,
MOA, major side effects and a few rare
• Read tips – will help you with how drugs are used
• Understand risk factors
CPS
• Know big sections
• Read monographs of important drugs
Rx Files
• Good supplement to learning (use at the end!!)
• Talks about unique and important SEs